EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

The Development of Biopharmaceuticals for Autoimmune Diseases

Dr. Thomas Nguyen

American Journal Of Pharmacy And Pharmacology · 2025-06-30 · 6 (3) · 1-4

DOI: 10.71465/ajpp.3373 ↗

At a glance

Journal article in American Journal Of Pharmacy And Pharmacology, published online on 2025-06-30. Written by Dr. Thomas Nguyen. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Biopharmaceuticals have transformed the treatment landscape for autoimmune diseases by offering targeted and effective therapeutic options. These biologically-derived agents, including monoclonal antibodies, cytokine modulators, and fusion proteins, are designed to modulate immune responses with high specificity. This article reviews the development of biopharmaceuticals in autoimmune disease therapy, highlighting key breakthroughs, clinical applications, safety considerations, and future research directions. The integration of biopharmaceuticals into treatment regimens represents a significant advancement in personalized and precision medicine.

Cite

APA

Nguyen, D. T. (2025). The Development of Biopharmaceuticals for Autoimmune Diseases. American Journal Of Pharmacy And Pharmacology, 6(3), 1-4. https://doi.org/10.71465/ajpp.3373

Vancouver

Nguyen DT. The Development of Biopharmaceuticals for Autoimmune Diseases. American Journal Of Pharmacy And Pharmacology. 2025;6(3):1-4. doi:10.71465/ajpp.3373

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Dr. Thomas},
  title = {The Development of Biopharmaceuticals for Autoimmune Diseases},
  journal = {American Journal Of Pharmacy And Pharmacology},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {1--4},
  doi = {10.71465/ajpp.3373}
}
Start for free →